17-63606395-G-GC
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_016360.4(TACO1):c.472dup(p.His158ProfsTer8) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
TACO1
NM_016360.4 frameshift
NM_016360.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.03
Genes affected
TACO1 (HGNC:24316): (translational activator of cytochrome c oxidase I) This gene encodes a mitochondrial protein that function as a translational activator of mitochondrially-encoded cytochrome c oxidase 1. Mutations in this gene are associated with Leigh syndrome.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-63606395-G-GC is Pathogenic according to our data. Variant chr17-63606395-G-GC is described in ClinVar as [Likely_pathogenic]. Clinvar id is 411.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TACO1 | NM_016360.4 | c.472dup | p.His158ProfsTer8 | frameshift_variant | 3/5 | ENST00000258975.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TACO1 | ENST00000258975.7 | c.472dup | p.His158ProfsTer8 | frameshift_variant | 3/5 | 1 | NM_016360.4 | P3 | |
TACO1 | ENST00000684587.1 | c.469dup | p.His157ProfsTer8 | frameshift_variant | 3/5 | A1 | |||
TACO1 | ENST00000581120.1 | n.674dup | non_coding_transcript_exon_variant | 3/4 | 2 | ||||
TACO1 | ENST00000682060.1 | n.234dup | non_coding_transcript_exon_variant | 3/5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Dec 03, 2018 | The homozygous p.His158ProfsTer8 variant in TACO1 was identified by our study in one individual with Mitochondrial Complex IV Deficiency. This variant was absent from large population studies. The homozygous p.His158ProfsTer8 variant in TACO1 has been reported in 5 Turkish individuals with Mitochondrial Complex IV Deficiency, and segregated with disease in 5 affected relatives from one cosanguineous family. Seven additional relatives, 1 without the variant and 6 with the variant in the heterozygous state, were unaffected (PMID: 19503089). This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 158 and leads to a premature termination codon 8 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. However, loss of function of the TACO1 gene is not an established disease mechanism in autosomal recessive Mitochrondrial Complex IV Deficiency based on the criteria laid out in Tayoun, 2018 (PMID: 30192042). In vitro functional studies with fibroblast mitochondria from a patient homozygous for this variant provide some evidence that the p.His158ProfsTer8 variant may impact protein function since Mitochondrial Complex IV levels were rescued by wild-type TACO1 expression (PMID: 19503089). However, these types of assays may not accurately represent biological function. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PS3, PP1 (Richards 2015). - |
Mitochondrial complex 4 deficiency, nuclear type 8 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2010 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at